You are here
Paul E. Croarkin, D.O., MSc
Dr. Croarkin’s research program focuses on adapting and innovating brain stimulation interventions in children and adolescents. This includes biomarker work to optimize diagnostic practices and the delivery of brain based interventions such as transcranial magnetic stimulation. A central theme focuses on the role of gamma-aminobutyric acid (GABA) and glutamate neurotransmitter systems in early-onset mood disorders with the goal of informing safer and more effective biologic treatments. This research is funded by a variety of industry, federal, and foundation grants. Dr. Croarkin is an associate professor of psychiatry and the division chair for child and adolescent psychiatry for the Mayo Clinic Department of Psychiatry and Psychology. In 2017 he received a National Institute of Mental Health Biobehavioral Research Award for Innovative New Scientists (BRAINS) for ongoing work focused on optimizing transcranial magnetic stimulation for adolescent depression. He is the current President of the Clinical TMS Society and is an active member of the annual meeting and research committees.